Patent · US Active

Promoter for introducing a gene into a lymphocyte or blood cell and application thereof

US8008467B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2006
Grant dateAug 30, 2011
Priority date
Expiry dateJul 14, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

It is intended to provide a promoter for inducing expression selectively and strongly in an immunocompetent cell and/or a blood cell such as a lymphocyte. In the invention, the object was achieved by finding that HHV6 MIE promoter, HHV7 MIE promoter and HHV7 U95 promoter unexpectedly induce a specific expression in an immunocompetent cell and/or a blood cell such as a T lymphocyte. By utilizing the promoters, a selective delivery of a DNA vaccine or the like can be realized.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.